CIRCULATING TUMOR DNA
Clinical trials for CIRCULATING TUMOR DNA explained in plain language.
Never miss a new study
Get alerted when new CIRCULATING TUMOR DNA trials appear
Sign up with your email to follow new studies for CIRCULATING TUMOR DNA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to wipe out hidden breast cancer cells
Disease control Recruiting nowThis study tests whether combining two drugs, sacituzumab govitecan and atezolizumab, can clear leftover cancer cells in the breast or lymph nodes after initial treatment. It includes 40 people with triple negative breast cancer who still have signs of cancer in their blood. The …
Matched conditions: CIRCULATING TUMOR DNA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 16, 2026 22:29 UTC
-
Blood test may catch lung cancer return early, study hopes to stop it
Disease control Recruiting nowThis study looks at whether a simple blood test can find tiny bits of cancer DNA left after lung cancer surgery. If the test shows cancer might come back, patients get extra treatment to try to stop it. The goal is to see if this approach can keep cancer away longer. About 66 peo…
Matched conditions: CIRCULATING TUMOR DNA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Blood test may spare some colon cancer patients from chemo
Knowledge-focused Recruiting nowThis study looks at whether a blood test that detects tumor DNA can help decide which stage II colon cancer patients need chemotherapy after surgery. About 1,320 patients will be randomly assigned to either have their treatment guided by the blood test or receive standard care. T…
Matched conditions: CIRCULATING TUMOR DNA
Phase: NA • Sponsor: UMC Utrecht • Aim: Knowledge-focused
Last updated May 16, 2026 22:33 UTC
-
Blood test could unlock cancer secrets for thousands of patients
Knowledge-focused Recruiting nowThis study is collecting blood samples from 1,000 people with digestive, gynecologic, or breast cancer to study tiny bits of tumor DNA and particles called exosomes floating in the blood. Researchers want to see if these markers can help predict how the cancer will behave, whethe…
Matched conditions: CIRCULATING TUMOR DNA
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated May 16, 2026 22:29 UTC
-
Breath and sputum tests could revolutionize lung cancer monitoring
Knowledge-focused Recruiting nowThis study looks at whether DNA from blood, sputum, and breath can help track non-small cell lung cancer before and after surgery. About 210 adults having surgery to remove their cancer will provide samples over 24 months. The goal is to see if these tests are practical and safe …
Matched conditions: CIRCULATING TUMOR DNA
Sponsor: St. Joseph's Healthcare Hamilton • Aim: Knowledge-focused
Last updated May 16, 2026 22:27 UTC
-
Can a simple blood test predict ovarian cancer relapse?
Knowledge-focused Recruiting nowThis study is for women newly diagnosed with a common type of ovarian cancer. Researchers will collect blood samples before surgery, after chemotherapy, and during follow-up treatment to look for tumor DNA. The goal is to see if this DNA test can predict how well the maintenance …
Matched conditions: CIRCULATING TUMOR DNA
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Blood test and survey combo could spot vulva cancer return earlier
Knowledge-focused Recruiting nowThis study looks at whether regular patient questionnaires and a special blood test (circulating tumor DNA) can detect vulva cancer recurrence earlier than standard follow-up. About 295 women with vulva cancer will be followed for two years, and their results will be compared to …
Matched conditions: CIRCULATING TUMOR DNA
Phase: NA • Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC